Literature DB >> 6710428

Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis.

F C de Beer, A E Nel, R P Gie, P R Donald, A F Strachan.   

Abstract

C-reactive protein and serum amyloid A protein levels were measured in 54 patients with pulmonary tuberculosis. The primary tuberculous complex was associated with an insignificant acute phase response, while post-primary tuberculosis without evidence of lung destruction caused modest increases in C-reactive protein and serum amyloid A protein. In most patients with post-primary pulmonary tuberculosis with significant pulmonary destruction there was a major acute phase response, with very high serum amyloid A protein and C-reactive protein levels. The response in these patients is most likely to be due to secondary bacterial infection in addition to infection by Mycobacterium tuberculosis. Patients with miliary tuberculosis showed a major acute phase response. Serum amyloid A protein and C-reactive protein levels decreased rapidly after initiation of treatment in the patients with post-primary tuberculosis without significant pulmonary destruction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6710428      PMCID: PMC459761          DOI: 10.1136/thx.39.3.196

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  Clinical experience with the C-reactive protein test.

Authors:  R J ROANTREE; L A RANTZ
Journal:  AMA Arch Intern Med       Date:  1955-11

2.  Degradation of amyloid-related serum protein SAA by a component present in rabbit and human serum.

Authors:  B Skogen; J B Natvig; A L Bøorresen; K Berg
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

Review 3.  Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

4.  Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis.

Authors:  F C De Beer; R K Mallya; E A Fagan; J G Lanham; G R Hughes; M B Pepys
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

5.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

6.  Amyloid protein SAA is associated with high density lipoprotein from human serum.

Authors:  E P Benditt; N Eriksen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

7.  Solid phase radioimmunoassays for human C-reactive protein.

Authors:  B Shine; F C de Beer; M B Pepys
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

8.  Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.

Authors:  G Lavie; D Zucker-Franklin; E C Franklin
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

  8 in total
  17 in total

1.  Sputum sol phase proteins and elastase activity in patients with clinically stable bronchiectasis.

Authors:  P Lloberes; E Montserrat; J M Montserrat; C Picado
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

2.  Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Alan Sher; Subash Babu
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

3.  Chronic pulmonary tuberculosis and anasarca: a classic revisited.

Authors:  Madhav Bansal; Kiran Pathak; Satish Pathak; Arjun Maitra; Mahesh Prasad; Sanjay Tandon; Rakesh Biswas
Journal:  BMJ Case Rep       Date:  2009-08-10

4.  Chronic bronchial sepsis and progressive lung damage.

Authors:  G M Cochrane
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-06

5.  Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.

Authors:  A Jayakumar; E Vittinghoff; M R Segal; W R MacKenzie; J L Johnson; P Gitta; J Saukkonen; J Anderson; M Weiner; M Engle; C Yoon; M Kato-Maeda; P Nahid
Journal:  Tuberculosis (Edinb)       Date:  2015-05-09       Impact factor: 3.131

6.  Serum levels of C-reactive protein in patients with pulmonary tuberculosis and malignant tumors of the chest.

Authors:  P Maasilta; A A Kostiala
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

7.  Antioxidant status, C-reactive protein and iron status in patients with pulmonary tuberculosis.

Authors:  Dhia A Taha; Imad A-J Thanoon
Journal:  Sultan Qaboos Univ Med J       Date:  2010-11-14

Review 8.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

9.  Peripheral blood leukocyte counts, erythrocyte sedimentation rate and C-reactive protein in tularemia caused by the type B strain of Francisella tularensis.

Authors:  H Syrjälä
Journal:  Infection       Date:  1986 Mar-Apr       Impact factor: 3.553

10.  Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

Authors:  Edward S Chen; Zhimin Song; Matthew H Willett; Shannon Heine; Rex C Yung; Mark C Liu; Steve D Groshong; Ying Zhang; Rubin M Tuder; David R Moller
Journal:  Am J Respir Crit Care Med       Date:  2009-11-12       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.